Trials / Conditions / Cardiovascular Events

Cardiovascular Events

26 registered clinical trials studyying Cardiovascular Events — 12 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	Statins to Prevent Cancer Associated Blood Clots NCT07303816	Brigham and Women's Hospital	Phase 4
Recruiting	Aspirin Continuation or Interruption in Patients at Moderate Risk for Cardiovascular Events Undergoing Colonos NCT07052799	Chinese University of Hong Kong	Phase 3
Recruiting	Cardiovascular Outcomes and Risk Evaluation Among Recipients of Hematopoietic Stem Cell Transplantation NCT07349498	Peking University People's Hospital	—
Recruiting	Tezspire Cardiac Events PASS NCT06951867	AstraZeneca	—
Recruiting	Further Lipid-Lowering With PCSK9 Inhibitors for Cardiovascular Outcomes in High-Risk Coronary Plaques Assesse NCT06863545	Second Affiliated Hospital, School of Medicine, Zhejiang University	N/A
Recruiting	Colchicine in Chronic Kidney Disease Patients NCT06998862	Hospital General Universitario Gregorio Marañon	Phase 3
Enrolling By Invitation	The Italian Registry of Patients with Chronic Obstructive Pulmonary Disease NCT06652776	University of Milan	—
Recruiting	Evaluation of Vulnerability of Carotid Plaques and Prediction of Cardio-Cerebrovascular Event Using Ultrasonic NCT06473272	Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine	—
Unknown	Weight Management of Dialysis Patients NCT06333574	qinxiu zhang	N/A
Recruiting	Fluad vs. Fluzone High-Dose Vaccine Effectiveness Among Adults ≥65 Years NCT06029933	Kaiser Permanente	—
Completed	Integrating Hepatological, Nutritional, and Psychological Support as a Multidisciplinary Management to Improve NCT07366463	University of Campania Luigi Vanvitelli	N/A
Recruiting	PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With ACS NCT05457582	Nanjing First Hospital, Nanjing Medical University	N/A
Recruiting	Menopause Related Influences on Leukocyte Distribution, Monocyte Function and Platelet Reactivity NCT05985447	Heinrich-Heine University, Duesseldorf	—
Active Not Recruiting	Comparative Effectiveness and Safety of Four Second Line Pharmacological Strategies in Type 2 Diabetes Study NCT05220917	Brigham and Women's Hospital	—
Unknown	Addiction in Intensive Cardiac Care Units NCT05063097	Assistance Publique - Hôpitaux de Paris	—
Recruiting	Tonometry(1) and Duplex Ultrasound(2) to Predict CV Events in to be Treated Patients With an AAA NCT04183426	Rijnstate Hospital	—
Completed	Tonometry and Duplex Ultrasound to Predict AAA Progression and CV Events in Aneurysm Patients (1-2-3 Trial) NCT03989011	Rijnstate Hospital	—
Unknown	Non-Invasive Aortic Ambulatory Blood Pressure Monitoring for The Detection of Target Organ Damage in The Chine NCT03154203	Shanghai 10th People's Hospital	—
Completed	Post-stroke Depression Treatment Effect on Stroke Recurrence NCT04776226	Ege University	N/A
Completed	Incidence and Prognostic Implication of Acute CV Events in Patients Hospitalized for CAP in Internal Medicine NCT03798457	Fadoi Foundation, Italy	—
Unknown	Social Medical Progression of Coronary Heart Disease With Associated Psychosocial Comorbidity -Interval Rehabi NCT01589536	Clinic Roderbirken	N/A
Terminated	A Randomized Controlled Trial of Aliskiren in the Prevention of Major Cardiovascular Events in Elderly People NCT01259297	Novartis Pharmaceuticals	Phase 3
Completed	Extended Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome NCT01223586	Kyoto University	—
Completed	Secondary Prevention Treatment in Patients Who Have Suffered a Cardiovascular Event NCT01395550	AstraZeneca	—
Completed	Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia NCT01755078	Chugai Pharma Taiwan	Phase 4
Completed	Circulating P3NP and Cardiovascular Events in Hemodialysis Patients NCT03391128	Toujinkai Hospital	—